The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group have agreed to supply Avifavir, the world’s first favipiravir-based drug registered against coronavirus infection and Russia’s first drug approved for the treatment of COVID-19, to 17 countries.
The drug has already been delivered to Belarus, Bolivia, Kazakhstan, Kyrgyzstan,...
